Akoya Biosciences Inc
AKYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.44M
Close$
Share Statistics
| Market cap | $64.44 Million |
|---|---|
| Enterprise Value | $144.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.12 |
| Beta | 1.35 |
| Outstanding Shares | 49,664,515 |
Return
| Return on Equity | 807.15% |
|---|---|
| Return on Assets | -42.20% |
| Return on Invested Capital | -845.54% |
Valuation & Multiples
| P/E Ratio | -2.69 |
|---|---|
| PEG | 8.05 |
| Price to Sales | 1.29 |
| Price to Book Ratio | -1.29 |
| Enterprise Value to Revenue | 1.81 |
| Enterprise Value to EBIT | -3.74 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.7 |
| Debt to Equity | -17.07 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 2.48% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | 14,000▲ 1300.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.25%▼ 0.07% |
|---|---|
| Total Invested | $16.30M▼ 50.36% |
| Investors Holding | 58▼ 9.00% |
ESG Score
No data
About Akoya Biosciences Inc
169 employeesAs The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow ...